nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina
|
Eizenberg, Peter |
|
2011 |
28 |
8 |
p. 640-649 |
artikel |
2 |
Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina
|
Eizenberg, Peter |
|
|
28 |
8 |
p. 640-649 |
artikel |
3 |
A shift in the treatment of hormone receptor and human epidermal growth factor receptor 2-positive metastatic breast cancer
|
Kemp, Zoe |
|
2011 |
28 |
8 |
p. 603-614 |
artikel |
4 |
Impact of infliximab adherence on Crohn’s disease-related healthcare utilization and inpatient costs
|
Carter, Chureen T. |
|
2011 |
28 |
8 |
p. 671-683 |
artikel |
5 |
Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB Trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE)
|
Mori, Yutaka |
|
2011 |
28 |
8 |
p. 698-706 |
artikel |
6 |
Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel
|
Pession, Andrea |
|
2011 |
28 |
8 |
p. 684-697 |
artikel |
7 |
The effect of the once-daily human glucagon-like peptide 1 analog liraglutide on the pharmacokinetics of acetaminophen
|
Kapitza, Christoph |
|
2011 |
28 |
8 |
p. 650-660 |
artikel |
8 |
The human papillomavirus (HPV) vaccine and cervical cancer: Uptake and next steps
|
Sheinfeld Gorin, Sherri N. |
|
2011 |
28 |
8 |
p. 615-639 |
artikel |
9 |
Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%
|
Scherzer, Maria-Luise |
|
2011 |
28 |
8 |
p. 661-670 |
artikel |
10 |
Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%
|
Scherzer, Maria-Luise |
|
|
28 |
8 |
p. 661-670 |
artikel |